- Type / Class
- Equity / COM NEW
- Total 13F shares
- 3,037,215
- Share change
- +178,515
- Total reported value
- $929,392
- Price per share
- $0.31
- Number of holders
- 27
- Value change
- +$57,233
- Number of buys
- 11
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 45408X308?
CUSIP 45408X308 identifies IGC - IGC Pharma, Inc. - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45408X308:
Top shareholders of IGC - IGC Pharma, Inc. - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
13,823,529
|
$4,700,000 | — | 22 Mar 2024 | |
| BlackRock, Inc. |
13F
|
Company |
—
class O/S missing
|
703,798
|
$200,582 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
700,014
|
$199,541 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
645,166
|
$183,872 | — | 31 Mar 2025 | |
| Rohit Goel |
3/4/5
|
Senior Director of Finance&PAO |
—
class O/S missing
|
235,000
|
$79,900 | — | 13 May 2021 | |
| STATE STREET CORP |
13F
|
Company |
—
class O/S missing
|
165,307
|
$47,113 | — | 31 Mar 2025 | |
| John E. Lynch |
3/4/5
|
Director |
—
mixed-class rows
|
396,901
mixed-class rows
|
$45,696 | — | 31 May 2022 | |
| Squarepoint Ops LLC |
13F
|
Company |
—
class O/S missing
|
140,510
|
$40,045 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
class O/S missing
|
113,407
|
$32,321 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
94,471
|
$26,924 | — | 31 Mar 2025 | |
| DEARBORN PARTNERS LLC |
13F
|
Company |
—
class O/S missing
|
84,401
|
$24,054 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
—
class O/S missing
|
65,541
|
$18,679 | — | 31 Mar 2025 | |
| TRUIST FINANCIAL CORP |
13F
|
Company |
—
class O/S missing
|
36,667
|
$10,450 | — | 31 Mar 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
—
class O/S missing
|
34,600
|
$10,000 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
—
class O/S missing
|
32,083
|
$9,144 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
—
class O/S missing
|
17,707
|
$5,046 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
13,353
|
$3,806 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
—
class O/S missing
|
7,187
|
$2,048 | — | 31 Mar 2025 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
—
class O/S missing
|
3,000
|
$870 | — | 31 Mar 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
—
class O/S missing
|
655
|
$177 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
604
|
$172 | — | 31 Mar 2025 | |
| Hurley Capital, LLC |
13F
|
Company |
—
class O/S missing
|
100
|
$29 | — | 31 Mar 2025 | |
| DHJJ Financial Advisors, Ltd. |
13F
|
Company |
—
class O/S missing
|
80
|
$23 | — | 31 Mar 2025 | |
| EVERMAY WEALTH MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
30
|
$9 | — | 31 Mar 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
14
|
$4 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
—
class O/S missing
|
5
|
$1 | — | 31 Mar 2025 |
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2025
As of 30 Jun 2025,
IGC Pharma, Inc. - COM NEW (IGC) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,037,215 shares.
The largest 10 holders included
BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, STATE STREET CORP, NORTHERN TRUST CORP, DEARBORN PARTNERS LLC, GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, and Virtu Financial LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
23
Q2 2025 holders
27
Holder diff
4
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.